Abraham N. Oler - Jan 14, 2022 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
SVP CORP DEV & GEN COUNSEL
Signature
/s/ Mark Guerin as attorney-in-fact
Stock symbol
ONTX
Transactions as of
Jan 14, 2022
Transactions value $
$3,300
Form type
4
Date filed
1/18/2022, 08:12 AM
Previous filing
Jan 10, 2022
Next filing
Jan 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONTX Common Stock Purchase $3.3K +1.5K +7.49% $2.20 21.5K Jan 14, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee.